Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mixed Panniculitis Secondary to Interferon Beta-1a Therapy in a Woman With Multiple Sclerosis.
Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.
Multiple sclerosis and palliative care - perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study.
Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
A Comparison of Supervised Machine Learning Algorithms and Feature Vectors for MS Lesion Segmentation Using Multimodal Structural MRI.
Combinatorial roles for histamine H(1) -H(2) and H(3) -H(4) receptors in autoimmune inflammatory disease of the central nervous system.
Purification of Mouse Brain Vessels.
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.
Confounding Psychosis in the Postpartum Period.
Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation.
Identity of the elusive IgM Fc receptor (FcmuR) in humans.
Endoplasmic reticulum dysfunction in neurological disease.
Quantification of gait kinematics and walking ability of people with multiple sclerosis who are new users of functional electrical stimulation.
The effects of bortezomib on the immune system: a focus on immune regulation.
Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis.
Corrigendum.
Fine-Tuning S1P Therapeutics.
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
Advances in Antioxidative Therapy of Multiple Sclerosis.
Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis.

Pages